Related Experiment Video
Updated: Mar 16, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Cardiogenic shock revisited: From hemodynamic-centric to multimodal precision care
Xuanqi An1, Chengliang Yin2, Haobo Xu1
1Emergency Department, National Clinical Research Center of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037 Beijing, China; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037 Beijing, China; National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, 100037 Beijing, China.
Cardiogenic shock (CS) is a complex condition with high mortality. Current treatments focusing on hemodynamics are insufficient, necessitating a shift towards precision care that addresses inflammation and microcirculatory dysfunction.
Area of Science:
- Cardiology
- Critical Care Medicine
- Translational Research
Background:
- Cardiogenic shock (CS) presents a significant clinical challenge with high short-term mortality despite advancements in supportive therapies.
- Current diagnostic and therapeutic strategies for CS are primarily hemodynamics-focused, limiting improvements in patient outcomes.
- Emerging evidence highlights the critical roles of inflammation, microcirculatory dysfunction, endothelial injury, and metabolic derangements in CS progression.
Purpose of the Study:
- To re-evaluate the conceptual evolution of cardiogenic shock.
- To examine the limitations of hemodynamic-centric approaches in diagnosing and treating CS.
- To advocate for a paradigm shift towards multimodal precision care for cardiogenic shock.
Main Methods:
- Review of historical and contemporary definitions and staging systems for CS.
- Analysis of current evidence implicating inflammatory and microcirculatory factors in CS.
- Exploration of novel diagnostic modalities including bedside microcirculation assessment, omics, advanced echocardiography, and AI.
Main Results:
- Hemodynamic-centric strategies have not significantly improved CS outcomes.
- Inflammatory activation, microcirculatory dysfunction, and metabolic derangements are key drivers of organ failure in CS.
- Multimodal diagnostic approaches offer potential for earlier recognition and precise classification of CS.
Conclusions:
- Cardiogenic shock should be viewed as a dynamic, multisystem disorder rather than solely a hemodynamic issue.
- A shift towards multimodal precision care, integrating various diagnostic tools, is crucial for improving CS management.
- Future clinical trials and management strategies must adopt a more comprehensive, systems-based approach to cardiogenic shock.
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Acute Coronary Syndrome IV: Interprofessional Care

